Skip to main content

CITADEL ADVISORS LLC

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1423053 MIAMI, FL

Position in CRBP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,827,092
-$36,499 QoQ
Shares Held
727,060
-13.8% QoQ
Ownership
3.92%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CRBP Over Time

Shares Held

Position Value (USD)

Derivatives in CRBP

reported options exposure · as of Mar 31, 2026
CallValue
$637,581
CallShares
67,900
PutValue
$108,924
PutShares
11,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,363,972 across 373 Biotechnology names. CRBP ranks #108 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRBP

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,827,092 727,060
2026-03-31 $108,924 11,600
2026-03-31 $637,581 67,900
2025-12-31 $6,863,591 843,193
2025-12-31 $459,910 56,500
2025-11-04 $11,031,862 980,610
2025-09-30 $304,865 24,100
2025-06-30 $149,730 21,700
2025-06-30 $112,470 16,300
2025-03-31 $493,781 92,991
2025-03-31 $38,232 7,200
2025-03-31 $116,289 21,900
2024-12-31 $206,500 17,500
2024-12-31 $492,060 41,700
2024-09-30 $1,322,383 64,100
2024-09-30 $1,367,769 66,300
2024-06-30 $15,057,435 332,761
2024-06-30 $470,600 10,400
2024-06-30 $176,475 3,900
2024-03-31 $372,780 9,500
2024-03-31 $329,616 8,400
2024-03-31 $14,486,112 369,167